Last reviewed · How we verify
Autologous Apheresis PRP Injection
Autologous Apheresis PRP Injection is a regenerative medicine treatment that uses a patient's own platelet-rich plasma to stimulate healing and tissue repair.
Autologous Apheresis PRP Injection is a regenerative medicine treatment that uses a patient's own platelet-rich plasma to stimulate healing and tissue repair. Used for Treatment of non-healing wounds, Treatment of osteoarthritis.
At a glance
| Generic name | Autologous Apheresis PRP Injection |
|---|---|
| Sponsor | zhang li |
| Drug class | Regenerative medicine |
| Modality | Biologic |
| Therapeutic area | Orthopedics, Wound care |
| Phase | Phase 2 |
Mechanism of action
The platelet-rich plasma is collected through a process called apheresis and then injected back into the patient. This process is thought to stimulate the release of growth factors and other signaling molecules that promote tissue repair and regeneration.
Approved indications
- Treatment of non-healing wounds
- Treatment of osteoarthritis
Common side effects
- Pain at injection site
- Swelling at injection site
- Bruising at injection site
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous Apheresis PRP Injection CI brief — competitive landscape report
- Autologous Apheresis PRP Injection updates RSS · CI watch RSS
- zhang li portfolio CI